Treatment outcome for adolescent obsessive-compulsive disorder in a specialized hospital setting.
Although few data are available concerning adolescents with obsessive-compulsive disorder (OCD), the existing literature suggests that cognitive-behavioral therapy (CBT) is the first-line treatment of choice for adolescents with mild to moderate OCD. A combination of CBT and serotonin reuptake inhibitors (SRIs) is recommended for more severe forms of OCD, based on the Expert Consensus Guidelines for the Treatment of Obsessive-Compulsive Disorder and the Pediatric OCD Treatment Study (POTS). Despite the effectiveness of CBT, a recent meta-analysis found that 27% of adolescent outpatients fail to show clinically significant improvement following CBT and many also fail to show improvement with pharmacotherapy. One alternative for those who do not improve with outpatient treatment is an intensive inpatient program. Within the last 10 years, two specialty hospitals have created programs that provide intensive CBT milieu treatment with multidisciplinary support (e.g., nursing, psychopharmacology) to treat adolescents with OCD. This naturalistic study describes treatment outcomes in 23 patients who received treatment in one of these programs between 2005 and 2006. Results suggest significant improvements on the majority of outcome measures, with 70% of the patients judged to meet criteria for clinically significant change. Thus, inpatient treatment appears potentially efficacious, although future controlled trials with larger samples are needed.
The Menninger Clinic and Baylor College of Medicine, Houston, TX 77080, USA. tbjorgvinsson@menninger.edu
Thröstur
T
Björgvinsson
Chad T
CT
Wetterneck
Dana M
DM
Powell
Gregory S
GS
Chasson
Sarah A
SA
Webb
John
J
Hart
Susan
S
Heffelfinger
Renee
R
Azzouz
Terri L
TL
Entricht
Joyce E
JE
Davidson
Melinda A
MA
Stanley
D000293:Adolescent; D001521:Behavior Therapy; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D015897:Comorbidity; D005260:Female; D005500:Follow-Up Studies; D006760:Hospitalization; D006778:Hospitals, Psychiatric; D006782:Hospitals, Special; D006801:Humans; D007902:Length of Stay; D008297:Male; D008884:Milieu Therapy; D009771:Obsessive-Compulsive Disorder / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D010043:Outcome and Process Assessment, Health Care; D010348:Patient Care Team; D010555:Personality Inventory; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D013781:Texas
D017367:Selective Serotonin Reuptake Inhibitors